398442_226408847488769_596859361_n <photo by Ellia Tu>   

林俞仲醫師發表之國際期刊論文:

1. Lin YC, Wynn JK, Hellemann G, Green MF. Factor structure of emotional intelligence in schizophrenia. Schizophr Res. 139(1-3):78-81. 2012(SCI:4.748)

2.Chen CJ, Chiu HJ, Lin YC (corresponding author). Deoxyribonucleic acid (DNA) Paternity Test Resolving Refractory Capgras Syndrome. Psychiatry and Clinical Neurosciences. 64(5):589. 2010 (SCI: 1.394)

3. Lin YC, Chen HZ, Chang TJ, Lane HY. Hypokalemia Following Rapid Titration of Quetiapine Treatment. Journal of Clinical Psychiatry.69(1):165-6.2008 (SCI: 5.053)

4. Lin YC, Su HK, Ouyang WC, Lane HY. Zotepin-Induced QTc Prolongation. Journal of Clinical Psychopharmacology. 28(5):576-8. 2008 (SCI: 4.371)

5. Chien IC, Lin YC, Chou YJ, Lin CH, Bih SH, Lee CH, Chou P. The treated prevalence and incidence of dementia among national health insurance enrollees in Taiwan, 1996–2003. Journal of Geriatric Psychiatry and Neurology. 21(2):142-148. 2008 (SCI: 1.794)

6. Chen CF and Hsu HC, Ouyang WC, Lin YC (corresponding author). Galantamine-induced Pisa syndrome: memantine as an alternative. Int J Geriatr Psychiatr. 23(6):660-1. 2008(SCI: 2.128)

7. Lin YC, Lin YC. Onychotillomania, major depressive disorder and suicide. Clinical and Experimental Dermatology. 31(4)597-599, 2006 (SCI: 1.779)

8. Wang CC, Lin YC, Shiu SF, Ouyang WC. Severe Rhabdomyolysis Possibly Complicated by Quetiapine Use in One Schizophrenia Patient Comorbid with Hyponatremia. Journal of Medicine and Health. 1(1):101-5. 2012

9. 林俞仲、藍先元。以傳統型或非傳統型抗精神病藥物治療精神分裂症病患的社交認知功能. 2009. (國立成功大學行為醫學研究所碩士論文)

  

研討會論文 (僅列出林醫師任第一作者之論文)

 

1. Lin YC, Chiu HJ. QTc Prolongation Induced by Coadministration of Olanzapine and Haloperidol. 48th Annual Conference of Taiwanese Society of Psychiatry, Tainan, Taiwan. Oct.27-28, 2012

2. Lin YC, Chiu HJ, Lin CN, Wu CL. The Association between Metabolic Parameters and Psychopathology in Chronic Patients with Schizophrenia. The 20th International Conference on Health Promoting Hospitals and Health Services, Taipei, Taiwan. Apr. 11-13, 2012

3. Lin YC,Huang YH. Chiang PC et al. Research about factors of affecting schizophrene’s willingness to use ePHR. The 5th International Symposium on Healthcare Information Management, Tainan, Taiwan. Mar. 10, 2010

4. Lin YC, Lane HY. Social Cognition in Schizophrenia Patients Treated with Typical vs. Atypical Antipsychotic Agents. 48th Annual Conference of Taiwanese Society of Psychiatry, Taipei, Taiwan. Nov. 7-8, 2009

5. Lin YC, Su HK, Ouyang WC, Lane HY. Zotepine-Induced QTc prolongation. 47th Annual Conference of Taiwanese Society of Psychiatry, Kaohsiung, Taiwan. Nov. 2008

6. Lin YC, Chen HZ, Chang TZ, Lane HY. Hypokalemia following rapid titration of quetiapine treatment. 46th Annual Conference of Taiwanese Society of Psychiatry, Taichung, Taiwan. Nov. 3-4, 2007

7. Lin YC, Ouyang WC, The prevalence and quality of life of depression and insomnia among the rural community dwelling elderly in solitude: A southern Taiwan Study. 45th Annual Conference of Taiwanese Society of Psychiatry, Taichung, Taiwan. Nov. 5-6, 2006

8. Lin YC,Yamaguchi T, Huang HL et al. Play and talk group by use of tunnel cubes (Kugelbahn) among schizophrenic patients at the day care ward, JMH (Part 3). 44th Annual Conference of Taiwanese Society of Psychiatry, Taipei, Taiwan. Nov, 2006

9. Lin YC,Yamaguchi T, Huang HL et al. Play and talk group by use of tunnel cubes (Kugelbahn) among schizophrenic patients at the day care ward, JMH (Part 2).7th Pacific Rim Regional Congress of Group Psychotherapy & 4th Asia Pacific Conference on Psychotherapy, Taipei, Taiwan. Sep. 26-28, 2005

10. Lin YC, Huang HL, Yamaguchi T et al. Play and talk group by use of tunnel cubes among schizophrenics at the day care ward, JMH. 14th World Congress of the World Association for Dynamic Psychiatry. Krakow, Poland; March 16-19, 2005

11. Lin YC, Lin YC. Onychotillomania portending suicide, 43th Annual Conference of Taiwanese Society of Psychiatry, Tainan, Taiwan. 2006 Nov. 2004

12. Lin YC, Hsueh KL. Differential Diagnosis and Treatment of Parkinson’s Disease with Psychotic Symptoms and Depressive Symptoms: A Case Report. 43th Annual Conference of Taiwanese Society of Psychiatry, Changhua, Taiwan. Nov 2-3. 2002  

 

擔任主持人/協同主持人之研究計畫:

 

1. Randomized, Double-blind, Parallel-group, Placebo-controlled, Confirmatory Study of SM-13496 (Lurasidone HCL) in Patients with Schizophrenia. 2013 (主持人, D1001056)   

2. Long-term Extension Study of SM-13496 (Lurasidone HCL) in Patients with Schizophrenia 2013 (主持人, D1001057)

3. A multicenter, randomized, double-blind, fixed-dose, 6-week trial of the efficacy and safety of asenapine compared with placebo in subjects with an acute exacerbation of schizophrenia. 2011-2013 (協同主持人, P06124)

4. Long-term extension trial of asenapine in subjects with schizophrenia.2011-2013 (協同主持人, P06125)

5. A Phase III, multi-center, randomized, 24 week, double-blind, parallel-group, placebo-controlled study to evaluate efficacy and safety of RO4917838 in stable patients with persistent, predominant negative symptoms of schizophrenia treated with antipsychotics followed by a 28 week, double-blind treatment period.2011-2013 (協同主持人, WN25306)

6. Phase III, multi-center, randomized, 12-week, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of RO4917838 in patients with sub-optimally controlled symptoms of schizophrenia treated with antipsychotics followed by a 40-week double-blind, parallelgroup, placebo-controlled treatment period. 2011-2013 (協同主持人, WN25309)

7. The Relationship among Smoking, Clinical Symptoms, Antipsychotic Medications, and Gene Polymorphisms in Schizophrenia Patients. 2010 (主持人, Research Project in Jianan Mental Hospital)

8. The Relationship among Smoking Cessation, Psychiatric Symptoms, and Antipsychotic Medications in Schizophrenic Patients. 2009 (主持人, Research Project in Jianan Mental Hospital)

9. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group StudyEvaluating Paliperidone Palmitate in the Prevention of Recurrence in Subjects With Schizophrenia. 2005-2008 (協同主持人, R092670-PSY-3001)

10. The psychiatric diagnosis and quality of life of the elderly living alone in Rende Township of Tainan County. 2005 (主持人, Research Project in Jianan Mental Hospital)

11. Play and talk therapeutic groups at the day care ward (PartⅢ). 2005 (主持人, Research Project in Jianan Mental Hospital)

12. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Response, Multicenter Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-Release Paliperidone (3,6, and 12 mg/day) in the Treatment of Subjects with Acute Mania and Mixed Episodes Associated with Bipolar I Disorder. 2006-2007 (協同主持人, R076477-BIM-3001)

13. A double blind, randomized, placebo controlled Trial of Aripiprazole plus Valproate in the Short-term and Long-term Treatment of Bipolar Disorder. 2007-2008 (協同主持人, 031-OTB-0701)

14. A randomized, double-blind, placebo-and active-controlled, parallel-group study to evaluate the efficacy and safety of risperidone long-acting injectable for the prevention of mood episodes in the treatment of subjects with bipolar I disorder. 2007-2010 (主持人, RIS-BMN-3001)

15. A randomized, double-Blind, placebo-and Active-controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of a Fixed Dosage of 1.5 mg/day of Paliperidone Extended Release (ER) in the Treatment of Subjects With Schizophrenia. 2007-2008 (協同主持人, R076477-SCH-4012)

16. The relationship between risperdal treatment and quality of life in patients with Alzheimer’s disease and BPSD. 2007-2008 (協同主持人, RIS-TWN-MA3)

17. Behavioral and psychological symptoms of dementia(BPSD)in Taiwan– An observational study. 2007-2008 (協同主持人, REM-TWN-MA5)

18. Randomized, Placebo-controlled, Double-blind, Parallel-group, Confirmatory Study of SM-13496 (Lurasidone HCL) in Patients with Schizophrenia. 2009-2010 (協同主持人, D1001002)     

 

    全站熱搜

    林俞仲 發表在 痞客邦 留言(0) 人氣()